A Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria（PNH）
Clinical trial NCT06561841 · COMPLETED
Trial details
- NCT number
- NCT06561841
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-17
- Primary completion
- 2025-04-02
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.